AH
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Full-length and N-terminally truncated recombinant interleukin-38 variants are similarly inefficient in antagonizing interleukin-36 and interleukin-1 receptors | Cell communication and signaling |  | 2025 | 64 | 24 | ||
| Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in mice | Frontiers in immunology | | 2024 | 91 | 23 | ||
| Oxidation-sensitive cysteines drive IL-38 amyloid formation | Cell reports | | 2024 | 99 | 15 | ||
| GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model | Frontiers in immunology | | 2024 | 143 | 31 | ||
| Cell Intrinsic IL-38 Affects B Cell Differentiation and Antibody Production | International journal of molecular sciences | | 2023 | 99 | 88 | ||
| Multifaceted roles of IL-38 in inflammation and cancer | Cytokine | | 2022 | 234 | 146 | ||
| Inhibition of IL-1β release from macrophages targeted with necrosulfonamide-loaded porous nanoparticles | Journal of controlled release | | 2022 | 360 | 279 |
